Tranexamic acid for the management of bleeding: a review of the clinical effectiveness and guidelines

Record ID 32014000137
Authors' recomendations: Overall, there is evidence to suggest treatment with tranexamic acid reduces mortality from trauma related bleeding. In addition, subgroup analysis suggests treatment with 3 hours of trauma is associated with decreased mortality. However, treatment beyond three hours of trauma may be associated with an increased risk of death.
Project Status: Completed
Year Published: 2013
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Humans
  • Tranexamic Acid
  • Time Factors
  • Survival Rate
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
Contact Email:
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.